Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating activities:
Net income (loss)	$ 4,432	$ (50,403)	$ 59,073
Adjustments to net income (loss):
Provision for (recovery of) bad debts	2,599	(467)	595
Deferred tax benefit	(31,565)	(10,102)	(2,739)
Depreciation and amortization	101,059	25,946	27,474
Amortization of debt discount and issuance costs	6,857	15,036	3,366
Interest paid-in-kind	0	0	3,421
Equity-based compensation	14,982	13,757	4,809
Contingent consideration	(4,507)	2,696	26,441
Warranty provision	4,152	516	953
Provision for inventory obsolescence	(859)	990	1,225
Changes in operating assets and liabilities, net of acquisition
Accounts receivable	(76,984)	(116,848)	(23,038)
Inventories	20,870	(88,184)	28,340
Income tax receivables	5,611	8,106	(16,530)
Prepaid expenses and other	19,124	(21,226)	1,101
Accounts payable	12,667	7,015	(50,519)
Accrued expenses and other	1,024	9,133	10,913
Income tax payable	(755)	(8,754)	6,870
Lease liabilities	3,784	221	0
Contingent consideration	0	0	(25,000)
Deferred revenue	59,002	(50,619)	(178,960)
Net cash provided by (used in) operating activities	141,493	(263,187)	(122,205)
Investing activities:
Purchase of property, plant and equipment	(10,619)	(3,357)	(1,338)
Acquisition of STI, net of cash acquired	(373,818)	0	0
Investment in equity security	0	(11,975)	0
Net cash used in investing activities	(384,437)	(15,332)	(1,338)
Financing activities:
Proceeds from Series A issuance	33,098	224,987	0
Proceeds from common stock issuance	15,885	120,645	145,532
Series A equity issuance costs	(1,893)	(7,195)	0
Common stock issuance costs	(450)	(3,873)	0
Dividends paid on Series A Preferred	(18,670)	(8,051)	0
Payments on revolving credit facility	(116,000)	(126,033)	(70)
Proceeds from revolving credit facility	116,000	126,033	0
Proceeds from issuance of other debt	20,188	0	0
Proceeds from issuance of convertible notes	0	413,321	0
Premium paid on capped call	0	(52,870)	0
Fees paid on issuance of convertible notes	0	(1,591)	0
Principal payments on term loan facility	(14,300)	0	(57,702)
Proceeds from term loan facility	0	0	575,000
Principal payments on other debt	(23,935)	(133,225)	(115,000)
Payments on related party loans	0	0	(45,558)
Payment of special distribution	0	0	(589,000)
Contingent consideration	(1,483)	(7,810)	0
Deferred offering costs	0	0	(6,464)
Debt issuance costs	0	(6,590)	(36,011)
Net cash provided by (used in) financing activities	8,440	537,748	(129,273)
Effect of exchange rate changes on cash and cash equivalent balances	735	0	0
Net change in cash and cash equivalents	(233,769)	259,229	(252,816)
Cash and cash equivalents, beginning of period	367,670	108,441	361,257
Cash and cash equivalents, end of period	133,901	367,670	108,441
Supplemental Cash Flow Information
Cash paid for interest	23,118	24,306	6,935
Cash paid for income taxes	10,739	13,318	31,103
Non-cash Investing and Financing Activities
Dividends accrued on Series A Preferred	6,389	0	0
Stock consideration paid for acquisition of STI	$ 200,224	$ 0	$ 0